van Veldhuisen D J, de Graeff P A, Crijns H J
Academisch Ziekenhuis, afd. Cardiologie. Thoraxcentrum, Groningen.
Ned Tijdschr Geneeskd. 1997 Mar 8;141(10):460-4.
It has for years been a matter of debate whether digoxin may/should be used in chronic heart failure with sinus rhythm. Interest in digoxin was renewed when it was found that the substance had a vagotonic as well as a sympatholytic effect in heart failure patients. A recent clinical trial led to the conclusion that although digoxin had no effect on the mortality among heart failure patients, it did lead to a reduction of the number of hospital admissions, particularly because of heart failure (indicating reduced morbidity and deceleration of the progression of the disease). Many heart failure patients continue to have symptoms in spite of treatment with diuretics and ACE inhibitors. As only few alternatives are available, many physicians in the near future will go on using digoxin in these patients- and as the recent study shows, rightly so.
多年来,地高辛是否可以/应该用于窦性心律的慢性心力衰竭一直存在争议。当发现该物质对心力衰竭患者具有迷走神经兴奋作用以及抗交感神经作用时,人们对地高辛的兴趣再次燃起。最近的一项临床试验得出结论,虽然地高辛对心力衰竭患者的死亡率没有影响,但它确实导致住院人数减少,特别是因心力衰竭导致的住院人数减少(表明发病率降低和疾病进展减缓)。尽管使用了利尿剂和血管紧张素转换酶抑制剂进行治疗,但许多心力衰竭患者仍有症状。由于几乎没有其他选择,在不久的将来,许多医生仍会继续在这些患者中使用地高辛——而且正如最近的研究所显示的,这样做是正确的。